IDEAS home Printed from https://ideas.repec.org/a/cup/jadres/v43y2003i02p194-206_03.html
   My bibliography  Save this article

Consumer Response to Print Prescription Drug Advertising

Author

Listed:
  • MEHTA, ABHILASHA
  • PURVIS, SCOTT C.

Abstract

Direct-to-consumer (DTC) prescription drug advertising has grown significantly over the last few years and extended into a variety of health conditions, even as the controversy around it continues. How do consumers feel about this advertising, who reads it, and what are the likely behavioral responses? This article attempts to answer these questions. Based on a sample of 1,475 women who are regular readers of magazines, consumer attitudes and response to print DTC advertising is explored. Results show that women generally value DTC advertising, and readership levels are substantial especially if the advertisement is about a symptom that the respondent has or may have. DTC advertisements also seem to encourage respondents to ask their doctors about what they saw advertised, and some respondents are likely to insist on prescriptions as well. Age and usership of prescription drugs significantly enhance the interest and response to this category of advertising.

Suggested Citation

  • Mehta, Abhilasha & Purvis, Scott C., 2003. "Consumer Response to Print Prescription Drug Advertising," Journal of Advertising Research, Cambridge University Press, vol. 43(2), pages 194-206, June.
    • Handle: RePEc:cup:jadres:v:43:y:2003:i:02:p:194-206_03
    as

    Download full text from publisher

    File URL: https://www.cambridge.org/core/product/identifier/S0021849903030174/type/journal_article
    File Function: link to article abstract page
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Stefan Stremersch & Aurélie Lemmens, 2009. "Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes," Marketing Science, INFORMS, vol. 28(4), pages 690-708, 07-08.
    2. Stremersch, S. & Lemmens, A., 2008. "Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes," ERIM Report Series Research in Management ERS-2008-026-MKT, Erasmus Research Institute of Management (ERIM), ERIM is the joint research institute of the Rotterdam School of Management, Erasmus University and the Erasmus School of Economics (ESE) at Erasmus University Rotterdam.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cup:jadres:v:43:y:2003:i:02:p:194-206_03. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Kirk Stebbing (email available below). General contact details of provider: https://www.cambridge.org/jar .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.